Zydus receives final approval from USFDA for Norelgestromin and Ethinyl Estradiol Transdermal System
Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day had annual sales of US $330 million in the United States
Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day had annual sales of US $330 million in the United States
The products will be manufactured at the company's facility in Bengaluru
The inspection was a cGMP Inspection and had ended with NIL observations
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
The products will be manufactured at the company's facility in Bengaluru
Strides Pharma Science Limited to acquire 100% in Strides Pharma Services Pvt Ltd.
The RCSed's Court of Regents comprises a group of distinguished and accomplished individuals in their field
The generous donation includes multiple medical equipments
The companies will spread the adoption of the latest HOS and Mass Spec technologies to help scientists improve the safety, stability, and effectiveness of biotherapeutics
Dr Jitendra Singh launches API Chapter of AFMC, Pune; inaugurates the first annual conference of API-AFMS Continuing Medical Education (CME) on “Emerging trends in the practice of Medicine”
Subscribe To Our Newsletter & Stay Updated